Biolife Solutions Incorporated (NASDAQ:BLFS)’s Stock Is Sell After More Market Selling

September 17, 2017 - By Louis Casey

 Biolife Solutions Incorporated (NASDAQ:BLFS)'s Stock Is Sell After More Market Selling

Investors sentiment increased to 2.33 in Q4 2016. Its up 0.83, from 1.5 in 2016Q3. It improved, as 3 investors sold BioLife Solutions Inc shares while 0 reduced holdings. 5 funds opened positions while 2 raised stakes. 267,289 shares or 5.47% less from 282,746 shares in 2016Q3 were reported.
Price T Rowe Assoc Md holds 0% of its portfolio in BioLife Solutions Inc (NASDAQ:BLFS) for 11,800 shares. 2,500 were reported by Ancora Limited Company. Pnc Finance Serv Gp Inc stated it has 0% in BioLife Solutions Inc (NASDAQ:BLFS). Blackrock Fund Advsr has 2,526 shares. Tower Capital Limited Com (Trc) owns 0% invested in BioLife Solutions Inc (NASDAQ:BLFS) for 862 shares. 22 were accumulated by Wells Fargo Mn. Hudock Gru Incorporated Limited Liability Co holds 0% or 43 shares in its portfolio. Blackrock Institutional Com Na accumulated 33,039 shares or 0% of the stock. State Bank Of America De owns 1 shares or 0% of their US portfolio. Geode Cap Mngmt Ltd Liability Corporation invested in 0% or 69,384 shares. Citadel Advsr Ltd Limited Liability Company invested 0% of its portfolio in BioLife Solutions Inc (NASDAQ:BLFS). Mai Capital invested in 0% or 14,881 shares. 1 were reported by Deutsche Financial Bank Ag. Creative Planning holds 143 shares or 0% of its portfolio. Community State Bank Na owns 250 shares.

The stock of Biolife Solutions Incorporated (NASDAQ:BLFS) registered an increase of 103.59% in short interest. BLFS’s total short interest was 447,500 shares in September as published by FINRA. Its up 103.59% from 219,800 shares, reported previously. With 219,800 shares average volume, it will take short sellers 2 days to cover their BLFS’s short positions. The short interest to Biolife Solutions Incorporated’s float is 7.07%.

The stock increased 2.32% or $0.11 on September 15, reaching $4.85. About 129,947 shares traded. BioLife Solutions Inc (NASDAQ:BLFS) has risen 37.27% since September 17, 2016 and is uptrending. It has outperformed by 20.57% the S&P500.

BioLife Solutions, Inc. is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The company has market cap of $64.16 million. The Company’s product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. It currently has negative earnings.

BioLife Solutions Inc (NASDAQ:BLFS) Ratings Coverage

Among 2 analysts covering BioLife Solutions (NASDAQ:BLFS), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioLife Solutions had 4 analyst reports since June 14, 2017 according to SRatingsIntel. As per Monday, July 31, the company rating was maintained by Maxim Group. Janney Capital upgraded the shares of BLFS in report on Wednesday, July 5 to “Buy” rating. Maxim Group maintained it with “Buy” rating and $600 target in Friday, August 11 report. Maxim Group maintained the shares of BLFS in report on Wednesday, June 14 with “Buy” rating.

More notable recent BioLife Solutions Inc (NASDAQ:BLFS) news were published by: which released: “BioLife Solutions Amends Existing Credit Facility” on January 10, 2017, also with their article: “BioLife Solutions’ (BLFS) CEO Michael Rice on Q1 2016 Results – Earnings Call …” published on May 11, 2017, published: “BioLife Solutions Announces Second Quarter 2017 Financial Results” on August 10, 2017. More interesting news about BioLife Solutions Inc (NASDAQ:BLFS) were released by: and their article: “BioLife Solutions Announces 2016 Revenue Growth of 28%” published on January 12, 2017 as well as‘s news article titled: “BioLife Solutions Reports 4th Quarter and Full Year 2016 Results” with publication date: March 09, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.